AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/102
IN-VIVO EFFICACY OF SM-20302, A GP IIB IIIA RECEPTOR ANTAGONIST, CORRELATES WITH EX-VIVO PLATELET INHIBITION IN HEPARINIZED BLOOD BUT NOT IN CITRATED BLOOD/
Authors: REBELLO SS HUANG JB SAITO K LUCCHESI BR
Citation: Ss. Rebello et al., IN-VIVO EFFICACY OF SM-20302, A GP IIB IIIA RECEPTOR ANTAGONIST, CORRELATES WITH EX-VIVO PLATELET INHIBITION IN HEPARINIZED BLOOD BUT NOT IN CITRATED BLOOD/, Arteriosclerosis, thrombosis, and vascular biology, 18(6), 1998, pp. 954-960
MYOCARDIAL EXPRESSION OF THE MESSENGER-RNAS ENCODING COMPLEMENT PROTEINS C3 AND C9 AFTER ISCHEMIA REPERFUSION EX-VIVO/
Authors: KILGORE KS MCGEER PL YAGOSHIMA K WASHINGTON RA NAYLOR KB LUCCHESI BR
Citation: Ks. Kilgore et al., MYOCARDIAL EXPRESSION OF THE MESSENGER-RNAS ENCODING COMPLEMENT PROTEINS C3 AND C9 AFTER ISCHEMIA REPERFUSION EX-VIVO/, The FASEB journal, 12(4), 1998, pp. 176-176
EX-VIVO REVERSAL OF HEPARIN-MEDIATED CARDIOPROTECTION BY HEPARANASE AFTER ISCHEMIA AND REPERFUSION
Authors: TANHEHCO EJ KILGORE KS NAYLOR KB LUCCHESI BR
Citation: Ej. Tanhehco et al., EX-VIVO REVERSAL OF HEPARIN-MEDIATED CARDIOPROTECTION BY HEPARANASE AFTER ISCHEMIA AND REPERFUSION, The FASEB journal, 12(4), 1998, pp. 196-196
CORRELATION BETWEEN THE IN-VIVO EFFICACY OF GPIIB IIIA RECEPTOR ANTAGONISTS AND EX-VIVO PLATELET INHIBITION - ROLE OF CALCIUM/
Authors: HUANG J REBELLO SS FAUL JD LUCCHESI BR
Citation: J. Huang et al., CORRELATION BETWEEN THE IN-VIVO EFFICACY OF GPIIB IIIA RECEPTOR ANTAGONISTS AND EX-VIVO PLATELET INHIBITION - ROLE OF CALCIUM/, The FASEB journal, 12(4), 1998, pp. 1113-1113
ANALYSIS OF HEPARINS CARDIOPROTECTIVE EFFECTS IN-VITRO
Authors: WASHINGTON RA KILGORE KS MURPHY K LITTLETON JM BOOTH EA LUCCHESI BR
Citation: Ra. Washington et al., ANALYSIS OF HEPARINS CARDIOPROTECTIVE EFFECTS IN-VITRO, The FASEB journal, 12(4), 1998, pp. 1982-1982
PHARMACOKINETICS AND PHARMACODYNAMICS OF SM-20302, A GPIIB IIIA RECEPTOR ANTAGONIST, IN ANESTHETIZED DOGS/
Authors: REBELLO SS HUANG JB SHIN WJ SAITO K KANEKO M SAITOH Y LUCCHESI BR
Citation: Ss. Rebello et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF SM-20302, A GPIIB IIIA RECEPTOR ANTAGONIST, IN ANESTHETIZED DOGS/, Journal of cardiovascular pharmacology, 32(3), 1998, pp. 485-494
ANTIFIBRILLATORY EFFICACY OF LONG-TERM TEDISAMIL ADMINISTRATION IN A POSTINFARCTED CANINE MODEL OF ISCHEMIC VENTRICULAR-FIBRILLATION
Authors: FRIEDRICHS GS ABREU JN DRISCOLL EM BORLAK J LUCCHESI BR
Citation: Gs. Friedrichs et al., ANTIFIBRILLATORY EFFICACY OF LONG-TERM TEDISAMIL ADMINISTRATION IN A POSTINFARCTED CANINE MODEL OF ISCHEMIC VENTRICULAR-FIBRILLATION, Journal of cardiovascular pharmacology, 31(1), 1998, pp. 56-66
EFFECT OF RAMIPRILAT OR CAPTOPRIL ON MYOCARDIAL INFARCT SIZE - ASSESSMENT IN CANINE MODELS OF ISCHEMIA ALONE AND ISCHEMIA WITH REPERFUSION
Authors: BLACK SC DRISCOLL EM LUCCHESI BR
Citation: Sc. Black et al., EFFECT OF RAMIPRILAT OR CAPTOPRIL ON MYOCARDIAL INFARCT SIZE - ASSESSMENT IN CANINE MODELS OF ISCHEMIA ALONE AND ISCHEMIA WITH REPERFUSION, Pharmacology, 57(1), 1998, pp. 35-46
THE SEMISYNTHETIC POLYSACCHARIDE PENTOSAN POLYSULFATE PREVENTS COMPLEMENT-MEDIATED MYOCARDIAL INJURY IN THE RABBIT PERFUSED HEART
Authors: KILGORE KS NAYLOR KB TANHEHCO EJ PARK JL BOOTH EA WASHINGTON RA LUCCHESI BR
Citation: Ks. Kilgore et al., THE SEMISYNTHETIC POLYSACCHARIDE PENTOSAN POLYSULFATE PREVENTS COMPLEMENT-MEDIATED MYOCARDIAL INJURY IN THE RABBIT PERFUSED HEART, The Journal of pharmacology and experimental therapeutics, 285(3), 1998, pp. 987-994
REDUCTION OF MYOCARDIAL INFARCT SIZE IN-VIVO BY CARBOHYDRATE-BASED GLYCOMIMETICS
Authors: KILGORE KS TANHEHCO EJ PARK JL NAYLOR KB ANDERSON MB LUCCHESI BR
Citation: Ks. Kilgore et al., REDUCTION OF MYOCARDIAL INFARCT SIZE IN-VIVO BY CARBOHYDRATE-BASED GLYCOMIMETICS, The Journal of pharmacology and experimental therapeutics, 284(1), 1998, pp. 427-435
ATTENUATION OF INTERLEUKIN-8 EXPRESSION IN C6-DEFICIENT RABBITS AFTERMYOCARDIAL ISCHEMIA REPERFUSION/
Authors: KILGORE KS PARK JL TANHEHCO EJ BOOTH EA MARKS RM LUCCHESI BR
Citation: Ks. Kilgore et al., ATTENUATION OF INTERLEUKIN-8 EXPRESSION IN C6-DEFICIENT RABBITS AFTERMYOCARDIAL ISCHEMIA REPERFUSION/, Journal of Molecular and Cellular Cardiology, 30(1), 1998, pp. 75-85
COMPLEMENT GENE-EXPRESSION BY RABBIT HEART - UP-REGULATION BY ISCHEMIA AND REPERFUSION
Authors: YASOJIMA K KILGORE KS WASHINGTON RA LUCCHESI BR MCGEER PL
Citation: K. Yasojima et al., COMPLEMENT GENE-EXPRESSION BY RABBIT HEART - UP-REGULATION BY ISCHEMIA AND REPERFUSION, Circulation research, 82(11), 1998, pp. 1224-1230
RECOMBINANT KUNITZ PROTEASE INHIBITOR DOMAIN OF THE AMYLOID BETA-PROTEIN PRECURSOR AS AN ANTICOAGULANT FOR EXTRACORPOREAL-CIRCULATION IN RABBITS
Authors: ANNICH G WHITE T DAMM D ZHAO YQ FAKHRI M MEINHARDT J REBELLO S LUCCHESI BR BARTLETT RH SCHMAIER AH
Citation: G. Annich et al., RECOMBINANT KUNITZ PROTEASE INHIBITOR DOMAIN OF THE AMYLOID BETA-PROTEIN PRECURSOR AS AN ANTICOAGULANT FOR EXTRACORPOREAL-CIRCULATION IN RABBITS, Circulation, 98(17), 1998, pp. 3817-3817
COMPLEMENT INHIBITORS IN MYOCARDIAL ISCHEMIA REPERFUSION INJURY/
Authors: LUCCHESI BR KILGORE KS
Citation: Br. Lucchesi et Ks. Kilgore, COMPLEMENT INHIBITORS IN MYOCARDIAL ISCHEMIA REPERFUSION INJURY/, Immunopharmacology, 38(1-2), 1997, pp. 27-42
REVIPARIN-SODIUM PREVENTS COMPLEMENT-MEDIATED MYOCARDIAL INJURY IN THE ISOLATED RABBIT HEART
Authors: PARK JL TANHEHCO EJ KILGORE KS GRALINSKI MR LUCCHESI BR
Citation: Jl. Park et al., REVIPARIN-SODIUM PREVENTS COMPLEMENT-MEDIATED MYOCARDIAL INJURY IN THE ISOLATED RABBIT HEART, Journal of cardiovascular pharmacology, 30(5), 1997, pp. 658-666
CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY
Authors: REBELLO SS MILLER BV BASLER GC LUCCHESI BR
Citation: Ss. Rebello et al., CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY, Journal of cardiovascular pharmacology, 29(2), 1997, pp. 240-249
TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/
Authors: REBELLO SS DRISCOLL EM LUCCHESI BR
Citation: Ss. Rebello et al., TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/, Stroke, 28(9), 1997, pp. 1789-1796
PREVENTION OF CAROTID-ARTERY THROMBOSIS BY ORAL PLATELET GPIIB IIIA ANTAGONIST IN DOGS/
Authors: MOUSA SA MU DX LUCCHESI BR
Citation: Sa. Mousa et al., PREVENTION OF CAROTID-ARTERY THROMBOSIS BY ORAL PLATELET GPIIB IIIA ANTAGONIST IN DOGS/, Stroke, 28(4), 1997, pp. 830-835
ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION
Authors: REBELLO SS BLANK HS ROTE WE VLASUK GP LUCCHESI BR
Citation: Ss. Rebello et al., ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 91-99
LU-51198, A HIGHLY SULFATED, LOW-MOLECULAR-WEIGHT HEPARIN DERIVATIVE,PREVENTS COMPLEMENT-MEDIATED MYOCARDIAL INJURY IN THE PERFUSED RABBITHEART
Authors: GRALINSKI MR PARK JL OZECK MA WIATER BC LUCCHESI BR
Citation: Mr. Gralinski et al., LU-51198, A HIGHLY SULFATED, LOW-MOLECULAR-WEIGHT HEPARIN DERIVATIVE,PREVENTS COMPLEMENT-MEDIATED MYOCARDIAL INJURY IN THE PERFUSED RABBITHEART, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 554-560
TEDISAMIL PROTECTS AGAINST VENTRICULAR-FIBRILLATION IN A CONSCIOUS CANINE MODEL OF SUDDEN CARDIAC DEATH
Authors: FRIEDRICHS CS ABREU JN COUSINS GR KERRICK GP CHI L LUCCHESI BR
Citation: Cs. Friedrichs et al., TEDISAMIL PROTECTS AGAINST VENTRICULAR-FIBRILLATION IN A CONSCIOUS CANINE MODEL OF SUDDEN CARDIAC DEATH, The FASEB journal, 10(3), 1996, pp. 189-189
SELECTIVE-INHIBITION OF THE ALTERNATIVE COMPLEMENT PATHWAY BY SCR1[DESLHR-A] PROTECTS THE ISOLATED RABBIT HEART FROM HUMAN COMPLEMENT-MEDIATED DAMAGE
Authors: GRALINSKI MR WIATER BC ASSENMACHER AN OZECK MJ LUCCHESI BR
Citation: Mr. Gralinski et al., SELECTIVE-INHIBITION OF THE ALTERNATIVE COMPLEMENT PATHWAY BY SCR1[DESLHR-A] PROTECTS THE ISOLATED RABBIT HEART FROM HUMAN COMPLEMENT-MEDIATED DAMAGE, The FASEB journal, 10(3), 1996, pp. 957-957
A SULFATED FRACTION OF HEPARIN INHIBITS HUMAN COMPLEMENT-MEDIATED DAMAGE OF THE EX-VIVO DISCORDANT MYOCARDIAL XENOGRAFT
Authors: OZECK MJ GRALINSKI MR PARK JL LUCCHESI BR
Citation: Mj. Ozeck et al., A SULFATED FRACTION OF HEPARIN INHIBITS HUMAN COMPLEMENT-MEDIATED DAMAGE OF THE EX-VIVO DISCORDANT MYOCARDIAL XENOGRAFT, The FASEB journal, 10(3), 1996, pp. 958-958
EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN ON COMPLEMENT-MEDIATED INJURYIN THE RABBIT ISOLATED HEART
Authors: PARK JL GRALINSKI MR PEREZ M LUCCHESI BR
Citation: Jl. Park et al., EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN ON COMPLEMENT-MEDIATED INJURYIN THE RABBIT ISOLATED HEART, The FASEB journal, 10(3), 1996, pp. 959-959
SYNTHETIC THROMBIN INHIBITOR CVS-1123 INHIBITS VENOUS AND ARTERIAL THROMBOSIS IN THE ACUTE CANINE MODEL
Authors: BASLER GC MILLER BV REBELLO S LUCCHESI BR
Citation: Gc. Basler et al., SYNTHETIC THROMBIN INHIBITOR CVS-1123 INHIBITS VENOUS AND ARTERIAL THROMBOSIS IN THE ACUTE CANINE MODEL, The FASEB journal, 10(3), 1996, pp. 2503-2503
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>